Home | Welcome to Contract Pharma   
Last Updated Monday, September 1 2014
Print

WuXi PharmaTech Invests in TruTag Technologies



Published April 8, 2014
Related Searches: Packaging tablets Development
WuXi PharmaTech (Cayman) Inc. has made an investment in TruTag Technologies, Inc., a developer of the edible, covert security platform designed to address product counterfeiting. WuXi and TruTag will also explore collaborations to offer WuXi’s customers the TruTag on-dose authentication solution to help prevent counterfeiting and enhance drug safety.
 
TruTag microtags (TruTags) are inert and edible and can be integrated into a product without packaging or labels. According to the company, the technology has millions of optical patterns that can be embedded into a TruTag, a dust-sized particle smaller than the width of a human hair. This technology allows pharmaceutical companies to be able to field-read finished tablets circulating in the wholesale and retail market to determine the authenticity and origin of medicines, including site and date of manufacture, lots, and other critical data.
 
"TruTag is very excited to work with WuXi to explore the development of our on-dose authentication solution for WuXi’s pharmaceutical customers,” said Dr. Hank C.K. Wuh, chairman of TruTag Technologies. “This innovative technology is an important new weapon in fighting the growing global problem of counterfeit drugs.”
 
"WuXi is pleased to invest in this cutting-edge technology and to explore its further development to enhance patient safety and protect our customers’ intellectual property,” said Dr. Ge Li, chairman and chief executive officer of WuXi PharmaTech. 
 


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On